| 000 | 01547 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515065114.0 | ||
| 264 | 0 | _c20071221 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1352-4585 | ||
| 024 | 7 |
_a10.1177/1352458507077621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCocco, E | |
| 245 | 0 | 0 |
_aMitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis. _h[electronic resource] |
| 260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cSep 2007 |
||
| 300 |
_a975-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xtherapeutic use |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMarchi, P | |
| 700 | 1 | _aSardu, C | |
| 700 | 1 | _aRusso, P | |
| 700 | 1 | _aPaolillo, A | |
| 700 | 1 | _aMascia, Mg | |
| 700 | 1 | _aSolla, M | |
| 700 | 1 | _aFrau, J | |
| 700 | 1 | _aLorefice, L | |
| 700 | 1 | _aMassole, S | |
| 700 | 1 | _aFloris, G | |
| 700 | 1 | _aMarrosu, Mg | |
| 773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 13 _gno. 8 _gp. 975-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1352458507077621 _zAvailable from publisher's website |
| 999 |
_c17016570 _d17016570 |
||